The following information about the PTTCP episodes was collected: platelet-count nadir, another cytopenia also documented at any ... not assigned to the ITP group. We classified thrombotic ...

CAMBRIDGE, Mass., March 11, 2025--(BUSINESS WIRE)--2seventy bio, Inc. (Nasdaq: TSVT), today announced a definitive merger agreement under which Bristol Myers Squibb ...

with their burden often extending to longer-term complications such as event recurrence and post-thrombotic syndrome (PTS). Few data exist on the overall economic burden of DVT and PE and their ...

Statistical analysis revealed that severe cytopenia and splenomegaly were significant prognostic factors for survival. Cytopenia and splenomegaly appear to be the main drivers for poor prognosis in ...

However, a notable omission in these guidelines is the absence of specific recommendations for patients with thrombotic thrombocytopenic purpura. Indeed, these patients are particularly susceptible to ...

CD19-targeted chimeric antigen receptor (CAR) T-cell therapy has achieved marvelous results in the treatment of patients with relapsed and/or refractory B-cell lymphomas, B-cell acute lymphoblastic ...

Correspondence to Dr Antonis Fanouriakis, Rheumatology and Clinical Immunology Unit, “Attikon” University Hospital, Athens 12462, Greece; afanour{at}med.uoa.gr Our objective was to update the EULAR ...

However, definite diagnosis requires re-exposure to PTZ following recurrent cytopenia, but this is unfeasible due to medical ethical considerations. To date, the exact incidence of PTZ-induced ...

View all available purchase options and get full access to this article.